# Haloperidol for the Treatment of Nausea and Vomiting in the ED

> **NCT04764344** · PHASE4 · COMPLETED · sponsor: **Western Michigan University School of Medicine** · enrollment: 60 (actual)

## Conditions studied

- Vomiting
- Nausea
- Abdominal Pain
- Cannabis Use

## Interventions

- **DRUG:** Haloperidol
- **DRUG:** Ondansetron

## Key facts

- **NCT ID:** NCT04764344
- **Lead sponsor:** Western Michigan University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2023-05-22
- **Final completion:** 2023-05-22
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04764344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04764344, "Haloperidol for the Treatment of Nausea and Vomiting in the ED". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04764344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*